Birzeit Pharmaceuticals Company announced unaudited consolidated preliminary financial results for year ended December 31, 2013. For the period, the company's net profit after taxes reached $5,480,204, compared with a net profit after taxes of $4,785,914 in the audited data for 2012, a net increase of 14.5%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.03 USD | +0.75% | -1.47% | -7.78% |
25/02 | Birzeit Pharmaceuticals Company Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
09/01 | What does the Gotham City report say about Grifols? | RE |
1st Jan change | Capi. | |
---|---|---|
-7.78% | 156M | |
+18.04% | 43.07B | |
+16.92% | 21.51B | |
+18.33% | 15.19B | |
+19.27% | 14.44B | |
+56.12% | 13.12B | |
-10.73% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+4.00% | 4.73B |
- Stock Market
- Equities
- BPC Stock
- News Birzeit Pharmaceuticals Company
- Birzeit Pharmaceuticals Company Announces Unaudited Consolidated Preliminary Financial Results for Year Ended December 31, 2013